PER 13.0% 13.0¢ percheron therapeutics limited

DMD Phase 2 Results in Q4 = Potential 5000% Gem, page-211

  1. 173 Posts.
    lightbulb Created with Sketch. 37
    $10 Million for Phase 2b trial ??? are you joking ? first of all even the management still didnt know about the trial size and design at this time they are still in discussion with the authorities in Europe so how will diamond know about the cost ? Just look at other companies and you will know more about clinical trial cost .
 
watchlist Created with Sketch. Add PER (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.